In the inflamed tissue of IBD patients, there is a high number of granzyme B-expressing CD19(+) and IgA(+) cells, which co-express CD27 and CD38, and can kill in vitro intestinal epithelial cells, raising the possibility that such cells could contribute to IBD-associated epithelial damage (223). Here, GZMB is linked to inflammatory bowel disease.